Key Drivers
- Margin Recovery
- Strong Liquidity
- High Leverage
AIAI Summary
Oscar has shifted from a speculative profitability turnaround to a durability test: its raised 2026 earnings outlook and 2027 margin targets support upside, but at new highs investors should demand evidence that ACA share gains and lower medical-loss ratios can persist through volatile utilization and a shrinking market.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin Recovery
- •Strong Liquidity
- •High Leverage
OSCR's strong quarterly earnings, margins, cash flow, and liquidity improvement support a constructive near-term outlook, but high leverage, accumulated losses, and weak recent annual profitability warrant caution.
Price Behavior
Key Price Behavior Insights:
- •Recovery intact
- •Momentum cooling
- •Key breakout
OSCR remains mildly bullish over the last month, but a pullback toward $31.75–$32.00 support is likely unless it breaks above $33.80 resistance.
Volatile rebound from $29.83 to $33.81 in early
Sentiment & News
Key News Insights:
- •Raised guidance
- •Membership surge
- •ACA headwinds
Oscar Health's raised guidance, surging membership, and improving momentum support a bullish outlook, though valuation, ACA-market contraction, and volatility warrant caution.
Positive operational momentum could support further upside, but elevated valuation and market pressures may increase risk
Similar Companies in Healthcare
Other companies in the same sector with AI ratings